Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Study Warns on Immunotherapy De-Escalation in Advanced Cancers

(MedPage Today) -- For patients with advanced or metastatic solid tumors who had initial responses to immune checkpoint inhibitors (ICIs), reducing dose intensity did not preserve efficacy, an interim analysis of the MOIO study suggested. For...

Study Warns on Immunotherapy De-Escalation in Advanced Cancers

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Crossing the Digital Validation Chasm

An iterative, risk-based, model-driven digital validation strategy enables rapid responses to process changes and innovative technological implementations that would be slow to validate using…

More from Wednesday 28 October →